-
Loading metrics
Efficacy and safety of moderate-intensity rosuvastatin plus ezetimibe versus high-intensity rosuvastatin monotherapy in the treatment of composite cardiovascular events with hypercholesterolemia: A meta-analysis
- Lingyan Liu,
- Yongkun Deng,
- Lei Li,
- Xingbiao Yang,
- Zhaoheng Yin,
- Yong Lai
x
- Published: November 13, 2024
- https://doi.org/10.1371/journal.pone.0310696